Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New AI-Powered swab test aims to spot viruses in minutes

NCT ID NCT05661032

Diagnosis Sponsor: Portsmouth Hospitals NHS Trust Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 30, 2026 · Last updated Sep 18, 2026 · Updated 3 times

Summary

This study tests a new technology called Pictura Bio that aims to detect respiratory viruses quickly and cheaply from nose or throat swabs. Researchers will collect samples from 1000 adults and children with suspected viral infections at a UK hospital. The data will be used to train the system's algorithms to improve accuracy, with the goal of developing a faster, simpler diagnostic tool for viruses like flu and COVID-19.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a quick, cheap, and accurate test for respiratory viruses, improving diagnosis and treatment decisions.
What could go wrong
This is an early proof-of-concept study. The system is still learning and may not yet be accurate enough for clinical use. It will not affect patient care during the trial.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2023

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Anybody with a suspected or confirmed respiratory virus illness (including both staff and patients)

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Provide informed, (parental/guardian, where appropriate) consent * Able to provide nasopharyngeal swab/aspirate specimens. * A clinical suspicion of a respiratory viral infection with one or more of the following symptoms: * Coryzal symptoms (runny nose, sneezing and/or nasal congestion) * New onset of cough * Sore throat * Head and/or Muscle aches * Fever or chills Exclusion Criteria: * Unable to comply with study procedures or where in the opinion of the investigator, undertaking a nasopharyngeal swab may be detrimental to the individual * Lacking capacity to consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Infections, respiratory are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

respiratory tract infectious disorder viral respiratory tract infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Infections, respiratory Respiratory tract infections

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital

    RECRUITING

    Portsmouth, Hampshire, PO6 3LY, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.